Skip to content
Episurf Medical to present at Redeye Life Science Day, held in Stockholm, November 21

Episurf Medical will present at Redeye Life Science Day, a small-cap investor conference, held in Stockholm on November 21 (Haymarket by Scandic). The event is arranged by Redeye and the company will be represented by CEO Pål Ryfors.

The presentation will be available on the company’s website after the presentation.

For full program and registration, see link. (https://carwww.redeye.se/live/ls-day-2018)

For more  information, please contact:
 

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

CisionBlockPro\Cision\FeedItem Object
(
    [HtmlCompanyInformation:protected] => 
    [HtmlContact:protected] => 
    [HtmlTitle:protected] => <h1 style="font-family: arial,helvetica,sans-serif;">Episurf Medical to present at Redeye Life Science Day, held in Stockholm, November 21</h1>
    [HtmlHeader:protected] => 
    [HtmlIntro:protected] => <p style="font-size: 10pt;font-family: arial,helvetica,sans-serif;"><span style="font-size: 10pt;"><strong></strong></span></p>
    [Body:protected] => Episurf Medical will present at Redeye Life Science Day, a small-cap investor conference, held in Stockholm on November 21 (Haymarket by Scandic). The event is arranged by Redeye and the company will be represented by CEO Pål Ryfors.
The presentation will be available on the company’s website after the presentation.
For full program and registration, see link. (https://carwww.redeye.se/live/ls-day-2018)
For more  information, please contact:
 
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
    [HtmlBody:protected] => <p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: arial, helvetica, sans-serif;">Episurf Medical will present at Redeye Life Science Day, a small-cap investor conference, held in Stockholm on November 21 (Haymarket by Scandic). The event is arranged by Redeye and the company will be represented by CEO P&aring;l Ryfors.</span></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: arial, helvetica, sans-serif;">The presentation will be available on the company&rsquo;s website after the presentation.</span></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: arial, helvetica, sans-serif;">For full program and registration, see link. (<a href="https://carwww.redeye.se/live/ls-day-2018">https://carwww.redeye.se/live/ls-day-2018</a>)</span></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: arial, helvetica, sans-serif;"><strong>For more &nbsp;information, please contact:<br /></strong>&nbsp;</span></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: arial, helvetica, sans-serif;">P&aring;l Ryfors, CEO, Episurf Medical<br /></span><span style="font-size: 10pt; font-family: arial, helvetica, sans-serif;">Tel:</span><span style="font-size: 10pt; font-family: arial, helvetica, sans-serif;">+46 (0) 709 62 36 69<br /></span><span style="font-size: 10pt; font-family: arial, helvetica, sans-serif;">Email:&nbsp;</span><a href="mailto:pal.ryfors@episurf.com">pal.ryfors@episurf.com</a></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;"><strong>About Episurf Medical</strong></span></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;"><em>Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical&rsquo;s Episealer&reg; personalised implants and Epiguide&reg; surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical&rsquo;s &mu;iFidelity&reg; system enables implants to be cost-efficiently tailored to each individual&rsquo;s unique injury for the optimal fit and minimal intervention. Episurf Medical&rsquo;s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company&rsquo;s website: www.episurf.com.</em></span></p>
    [ServiceCategories:protected] => Array
        (
            [0] => CisionBlockPro\Cision\ServiceCategory Object
                (
                    [ServiceName:protected] => Twitter
                    [Name:protected] => Twitter
                    [Value:protected] => 9341
                )
            [1] => CisionBlockPro\Cision\ServiceCategory Object
                (
                    [ServiceName:protected] => LinkedIn
                    [Name:protected] => LinkedIn
                    [Value:protected] => 9309
                )
        )
    [LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
    [CompanyInformation:protected] => 
    [Contact:protected] => 
    [Header:protected] => 
    [Keywords:protected] => Array
        (
            [0] => Episurf Medical
            [1] => EpiSurf
        )
    [QuickFacts:protected] => Array
        (
        )
    [Categories:protected] => Array
        (
        )
    [Videos:protected] => Array
        (
        )
    [Files:protected] => Array
        (
            [0] => CisionBlockPro\Cision\File Object
                (
                    [IsMain:protected] => 1
                    [MediaType:protected] => File
                    [Url:protected] => https://mb.cision.com/Main/14691/2674371/946117.pdf
                    [FileName:protected] => wkr0006.pdf
                    [Title:protected] => Episurf Medical to present at Redeye Life Science Day, held in Stockholm, November 21
                    [Description:protected] => Episurf Medical to present at Redeye Life Science Day, held in Stockholm, November 21
                    [CreateDate:protected] => 2018-11-16T10:35:05Z
                    [Keywords:protected] => Array
                        (
                        )
                    [Extension:protected] => pdf
                )
        )
    [Quotes:protected] => Array
        (
        )
    [ExternalLinks:protected] => Array
        (
        )
    [EmbeddedItems:protected] => Array
        (
        )
    [Id:protected] => 3121482
    [EncryptedId:protected] => 3A17AEF237D26FAB
    [IsRegulatory:protected] => 
    [PublishDate:protected] => 2018-11-16T10:35:00Z
    [LastChangeDate:protected] => 2018-11-16T10:35:05Z
    [Title:protected] => Episurf Medical to present at Redeye Life Science Day, held in Stockholm, November 21
    [Intro:protected] => 
    [IptcCode:protected] => 04016003
    [InformationType:protected] => PRM
    [LanguageCode:protected] => en
    [CountryCode:protected] => se
    [CanonicalUrl:protected] => 
    [CisionWireUrl:protected] => https://news.cision.com/episurf/r/episurf-medical-to-present-at-redeye-life-science-day--held-in-stockholm--november-21,c2674371
    [LanguageVersions:protected] => Array
        (
        )
    [Images:protected] => Array
        (
        )
    [Tickers:protected] => Array
        (
            [0] => stdClass Object
                (
                    [Symbol] => EPIS B
                    [ISIN] => SE0003491562
                    [PrimaryListing] => 1
                    [IsShare] => 1
                    [MarketPlaceSymbol] => STO
                    [MarketPlaceName] => Stockholmsbörsen
                    [MarketPlaceBloombergCode] => SS
                    [MarketPlaceMarketWireCode] => OMX
                    [MarketPlaceIsRegulated] => 1
                    [MarketPlaceCountryCode] => SE
                )
        )
)